Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer

By Viteri Ainhoa   Muñoz Alberto   Rubio Itziar   Barceló Ramón   Martínez-Bueno Alejandro   Fernández Ricardo   Carrera Sergio   López-Vivanco Guillermo  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 397-399

Informa Healthcare

Access to resources Recommend Favorite

Role of low dose capecitabine combined to irinotecan in advanced and metastatic gastric cancer

By Farhat Fadi   Kattan Joseph   Chahine Georges   Younes Fariha   Nasr Fadi   Mroue Raghda   Ghosn Marwan  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 722-727

Humana Press, Inc

Access to resources Recommend Favorite

Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer

By Quek Richard   Lim Wan Teck   Foo Kian Fong   Koo Wen Hsin   A-Manaf Afidah   Toh Han Chong  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 1032-1034

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel combined with capecitabine as firstline chemotherapy for advanced or recurrent gastric cancer

By          

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 351-354

Spandidos Publications

Access to resources Recommend Favorite

Capecitabine in the treatment of colorectal cancer

By O’Neill VJ   Cassidy J  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 183-190

Future Medicine

Access to resources Recommend Favorite